Is this a Prime Time To acquire Exagen Inc. (XGN) stock

After finishing at $2.55 in the prior trading day, Exagen Inc. (NASDAQ: XGN) closed at $3.40, up 33.33%. In other words, the price has increased by $+0.8400 from its previous closing price. On the day, 381759 shares were traded. XGN stock price reached its highest trading level at $3.8500 during the session, while it also had its lowest trading level at $2.5000.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



Our goal is to gain a better understanding of XGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.30 and its Current Ratio is at 9.30. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.45.

Upgrades & Downgrades

On April 15, 2021, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $25.Canaccord Genuity initiated its Buy rating on April 15, 2021, with a $25 target price.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1.28 while its Price-to-Book (P/B) ratio in mrq is 0.90.

Stock Price History:

Over the past 52 weeks, XGN has reached a high of $12.65, while it has fallen to a 52-week low of $2.10. The 50-Day Moving Average of the stock is 2.8451, while the 200-Day Moving Average is calculated to be 5.5649.

Shares Statistics:

The stock has traded on average 53.07K shares per day over the past 3-months and 185.78k shares per day over the last 10 days, according to various share statistics. A total of 17.06M shares are outstanding, with a floating share count of 9.62M. Insiders hold about 21.28% of the company’s shares, while institutions hold 76.40% stake in the company. Shares short for XGN as of Oct 13, 2022 were 30.26k with a Short Ratio of 0.02M, compared to 29.77k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.19% and a Short% of Float of 0.29%.

Earnings Estimates

Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.73 for the current quarter, with a high estimate of -$0.58 and a low estimate of -$0.8, while EPS last year was -$0.42. The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.54 and low estimates of -$0.79.

Analysts are recommending an EPS of between -$2.83 and -$2.98 for the fiscal current year, implying an average EPS of -$2.89. EPS for the following year is -$2.34, with 6 analysts recommending between -$1.89 and -$3.1.

Revenue Estimates

A total of 6 analysts have provided revenue estimates for XGN’s current fiscal year. The highest revenue estimate was $39.5M, while the lowest revenue estimate was $36.5M, resulting in an average revenue estimate of $38.1M. In the same quarter a year ago, actual revenue was $48.3M, down -21.10% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $52.77M in the next fiscal year. The high estimate is $60.4M and the low estimate is $38.2M. The average revenue growth estimate for next year is up 38.50% from the average revenue estimate for this year.